Post-earnings recap
Reported
Thu, Mar 15, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported a loss per share of $0.04, but there was no revenue reported. The stock reaction was neutral, remaining unchanged at 0.00%, indicating that investors may have anticipated these results or are waiting for more information.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.04 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.